LAT2 and pancreatic neoplasm: Mechanistically, LAT2 could regulate the glutamine/p-mTORSer2448/glutamine synthetase feedback loop to keep mTOR activated and to upregulate LDHB in order to activate glycolysis, thereby promoting chemoresistance in pancreatic cancer cells.